In toxicology studies and clinical trials of erythritol, treated animals and human subjects had higher urine &gamma;-glutamyl transpeptidase [&gamma;-glutamyl transferase (&gamma;-GT)] than untreated controls. It has previously been reported that &gamma;-GT activity in frozen urine decreases with time; therefore, a study was undertaken to examine the effects of storage temperature, time, and the presence of erythritol on the stability of &gamma;-GT and N -acetyl glucosaminidase in human urine. In this study, it was found that the rate of decrease of the activity of &gamma;-GT is much greater at -20&deg;C than at -70&deg;C. Variation in the storage temperature of the frozen urine is particularly deleterious to &gamma;-GT. The addition of erythritol in a concentration of 5% reduces this decrease. Approximately 15% of N-acetyl glucosaminidase activity is lost in the initial process of freezing the urine. Thereafter, conditions of temperature, time, and the presence or absence of erythritol account for little additional loss of activity.
INTRODUCTION
Erythritol is a sweet-tasting, naturally occurring 4-carbon sugar alcohol. It is absorbed through the intestine, not metabolized by mammalian enzyme systems, and largely excreted unchanged in the urine (1) .
The instability of y-glutamyl transpeptidase (y-GT) (EC 2.3.2.2) in frozen urine, particularly at -20°C, has been previously reported (5, 6, 8) . In some clinical and animal studies, it was observed that individuals given erythritol had higher activity of urine y-GT than untreated controls (2, 10, 11) . As an increase in urinary ~y-GT may be interpreted as an indication of renal damage, it was necessary to determine whether such increases were real or an artifact of urine storage. In light of the low urinẽ y-GT noted in the untreated controls, the possibility was considered that erythritol in the urine may protect against loss of the enzyme activity, as has been demonstrated for glycerol, a 3-carbon alcohol (6, 8) . To resolve these questions, this in vitro study was conducted to investigate the effect of erythritol on the activities of y-GT and N-acetyl glucosaminidase (NAG) (EC 3.2.1.30) in human urine under various storage conditions relevant to the findings of treatment-related differences in clinical and animal studies of erythritol.
MATERIALS AND METHODS
Urine Samples. Urine samples were obtained from 6 healthy male volunteers. The urine was collected in the morning but was not first morning urine. The volunteers were fasting at the time of collection and had consumed 8 oz of water that morning. Each urine sample consisted of at least 140 ml. Three of the urine samples were at least 180 ml. The urine samples were immediately chilled in a wet ice bath and held at 4 ~-2°C. Routine urinalyses, osmolality, and urine electrolytes were determined on each urine sample within 4 hr following collection. All results were within normal limits. For each subject, the urine sample was divided into 2 parts. Erythritol was added to one of these, to achieve a final concentration of 5%, whereas none was added to the other. This is consistent with the concentration of erythritol measured in the urine of human subjects and animals receiving erythritol in medium to high doses.
The urine from each subject was then divided into 12 10-ml aliquots in 15-ml screw-cap plastic centrifuge tubes. For each subject, 1 tube of urine with 5% erythritol and 1 without erythritol were held at 4 ~-2°C for the initial enzyme determinations. Three tubes of urine with 5% erythritol and 3 tubes without erythritol were placed into a -20°C domestic freezer. Two tubes of urine with 5% erythritol and 2 tubes without erythritol were flashfrozen in a bath of methanol and dry ice and then placed into a -70°C mechanical freezer. From the subjects who had furnished at least 180 ml of urine, an additional tube of urine with 5% erythritol and an additional tube of urine without erythritol were frozen and stored at -20°C and at -70°C, as already described.
y-GT and NAG were determined within 6 hr of collection on the refrigerated urine samples without and with 5% erythritol. These values are considered to be the baseline results on the 6 subjects, as presented in Table I . One of each of the paired aliquots of urine without and with 5% erythritol from both the -20°C and the -70°C freezer was thawed at 24 hr. One of each aliquot of urine without and with 5% erythritol from both the -20°C and the -70°C freezer from the 3 volunteers who had furnished at least 180 ml of urine was thawed at 7 days. One of each aliquot of urine without and with 5% erythritol from both the -20°C and the -70°C freezer was thawed at 30 days. At each time point, the paired tubes of urine were allowed to thaw in a wet ice bath. When the urine had thawed completely, it was vortexed and y-GT and NAG were determined. The remaining urine was allowed to stand at room temperature (20-23°C). When its temperature reached room temperature (actual temperature recorded), the urine was again vortexed, and y-GT and NAG were determined.
For each subject, a 10-ml aliquot of urine containing 5% erythritol was centrifuged at 3,000 rpm for 10 min in a refrigerated centrifuge at 4 ± 2°C. Another 10-ml aliquot of urine also containing 5 % erythritol was not centrifuged. The uncentrifuged urine and the supernatant from the centrifuged urine were placed into a -20°C freezer for 30 days. Both were thawed as previously described (4°C followed by room temperature), and y-GT and NAG were determined.
A 10-ml aliquot of urine without erythritol and a 10-ml aliquot of urine with 5% erythritol from each subject were stored in a -20°C freezer for 24 hr. Both aliquots were removed from the freezer and placed on dry ice for 1 hr and then returned to the -20°C freezer for 29 additional days. This simulated the handling of the urine in one of the earlier oral safety studies. Both tubes of urine were thawed as previously described (4°C followed by room temperature), and y-GT and NAG were determined.
Determination of y-GT and NAG. y-GT and NAG were determined without dialysis on a Hitachi 717 analyzer (Boehringer Mannheim Corporation, Indianapolis, IN). q-GT was determined by a modification of the method of Szasz (7, 9) at 37°C using BMD reagents 1050672 (Boehringer Mannheim Corporation). Results were expressed as units per liter. NAG was determined at 37°C using BMD reagents 875406 (Boehringer Mannheim Corporation) and expressed as units per liter (3) . Each assay was performed in duplicate, and the mean of the 2 results was reported. All runs were in control, and the mean of each pair of assays was accepted if the 2 answers n were within 5% of the mean.
Statistical Methods. Results of y-GT and NAG deter-TABLE IV.-Influences of storage duration and/or presence of erythritol on urine y-GT at -20°C (statistical significance of pairwise comparisons).&dquo; Key: Erythritol: 0 = no erythritol; + = 5% erythritol added; -= not statistically significant; * = statistically significant at p < 0.05; ** = statistically significant at p < 0.01; *** = statistically significant at p < 0.001. a Comparisons are for 6 urine samples, except comparisons involving day 7, which are for 3 urine samples.
b Urine held at -20°C for 24 hours, placed on dry ice for 1 hr, and then returned to -20°C for the balance of 30 days.
minations were analyzed using an analysis of variance.
The model used included the factors of treatment group (erythritol: yes or no), storage conditions, and the interaction of treatment group and storage conditions. The model also included subject-related effects. Following the analysis of variance, pairwise comparisons were performed using the least significant difference.
Statistical significance was declared if the 2-sided pvalue was ~0.05.
RESULTS AND DISCUSSION
The baseline values of the y-GT and NAG are given in Table I . As urine y-GT and NAG have been shown to be stable for up to 24 hr at 4°C (5, 6, 8) , the initial value of each enzyme in urine without erythritol is taken to be the true value for that subject. The reference values are for males, calculated from Maruhn et al (4) .
Overall, the mean value of the initial activities of y-GT and NAG in urine samples to which 5% erythritol was added were approximately 5% lower than those in the urine samples without erythritol. This appears to be the simple result of dilution, demonstrating that erythritol is neither an activator nor an inhibitor of q-GT or NAG in urine.
In Tables II and III, the determined enzymatic activity for -y-GT and NAG, respectively, under the various storage conditions, is expressed as percentage of the baseline value. At -20°C, the activity of y-GT decreased markedly with time. A still greater decrease occurred when frozen urine, stored at -20°C was removed from the freezer after 24 hr of storage, placed on dry ice for 1 hr, and returned to the -20°C freezer for the balance of 30 days. In simulating this event, the temperature of the frozen liquid at -20°C, placed on dry ice fell to -60°C in 10 min.
The statistical significance of all pairwise comparisons of treatments (i.e., without or with 5% erythritol) and storage conditions is shown for y-GT at -20°C and at -70°C in Tables IV and V, respectively. The statistical TABLE V.-Influences of storage duration and/or presence of erythritol on urine y-GT at -70°C (statistical significance of pairwise comparisongs) a Key: Erythritol: 0 = no erythritol; + = 5% erythritol added; -= not statistically significant; * = statistically significant at p < 0.05; ** = statistically significant at p < 0.01. I Comparisons are for 6 urine samples, except comparisons involving day 7, which are for 3 urine samples. analysis indicated that there was a highly significant (p < 0.01) interaction between treatment and storage conditions for q-GI suggesting that the differences among the conditions depended on the treatment. Under all conditions, 5% erythritol reduced but did not prevent the loss of y-GT activity, indicating a stabilizing effect of erythritol on ~y-GT activity.
The decrease in activity of NAG under described storage conditions was not as great as that of ~y-GT Although the data suggest that erythritol may be slightly protective of NAG activity, and that NAG activity was preserved better at -70°C than at -20°C, the data were somewhat inconsistent. It appears that there is a notable reduction in NAG activity when the urine samples with or without erythritol were stored at -20°C or -70°C for 7 days and that this reduction tends to disappear when the samples were stored for 30 days. However, it should be emphasized that the data for the storage conditions at 7 days are based on only 3 of the 6 subjects while all other comparisons were based on the data collected from all 6 subjects. Overall, the data indicate that freezing at either -20°C or -70°C reduced the activity of NAG by ap-TABLE VI.-Influences of storage duration and/or presence of erythritol on urine NAG at -20°C (statistical significance of pairwise comparisons).a Key: Erythritol: 0 = no erythritol; + = 5% erythritol added; -= not statistically significant; * = statistically significant at p < 0.05; ** = statistically significant at p < 0.01; *** = statistically significant at p < 0.001. a Comparisons are for 6 urine samples, except comparisons involving day 7, which are for 3 urine samples.
b Urine held at -20°C for 24 hr, placed on dry ice for 1 hr, and then returned to -20°C for the balance of 30 days. Key: Erythritol: 0 = no erythritol; + = 5% erythritol added; -= not statistically significant; * = statistically significant at p < 0.05; ** = statistically significant at p < 0.01; *** = statistically significant at p < 0.001. a Comparisons are for 6 urine samples, except comparisons involving day 7, which are for 3 urine samples. proximately 15% and that the other factors investigated played only a minor role in the remaining enzymatic activity.
The statistical significance of all pairwise comparisons of treatments (i.e., without or with 5% erythritol) and storage conditions is given for NAG at -20°C in Table   VI and for NAG at -70°C in Table VII . The interaction between erythritol treatment and storage conditions was not statistically significant.
The effect of freezing the supemate of centrifuged urine and uncentrifuged urine was also compared. For this experiment, aliquots of urine containing 5% erythritol were frozen at -20°C for 30 days. There was no significant difference in either y-GT or NAG activities between the supemate of centrifuged urine and uncentrifuged urine. There was no significant difference in either q-GT or NAG between thawed, well-mixed refrigerated urine samples and those brought to room temperature (20-23°C) prior to analysis; therefore, results on specimens brought to room temperature are not reported or discussed further.
Overall, the results of this study demonstrate that y-GT in human urine is very labile to storage at -20°C but is fairly well preserved if immediately flash-frozen in a bath of methanol and dry ice and stored at -70°C. The presence of 5% erythritol exerts a stabilizing effect on q-GT in human urine. Storage conditions and the presence of erythritol do not appear to affect significantly the stability of NAG in frozen human urine.
This study documents that the interaction of test article in urine with conditions of storage may lead to statistically significant differences in measured analytes between treated and control subjects.
